At the World Congress of Endourology and Uro-Technology, Aymon Ali presented the first US experience with the HyperQure extravascular renal denervation system for treatment-resistant hypertension, targeting the 10% of hypertensive patients who remain uncontrolled despite maximum medical therapy.
|